Does EVOLOCUMAB Cause Laryngitis? 108 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Laryngitis have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.1% of all adverse event reports for EVOLOCUMAB.
108
Reports of Laryngitis with EVOLOCUMAB
0.1%
of all EVOLOCUMAB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Laryngitis From EVOLOCUMAB?
Of the 108 reports, 5 (4.6%) required hospitalization.
Is Laryngitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 108 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Laryngitis?
ADALIMUMAB (893)
METHOTREXATE (740)
TOFACITINIB (683)
ETANERCEPT (677)
TOCILIZUMAB (657)
SECUKINUMAB (654)
RITUXIMAB (628)
ABATACEPT (621)
DICLOFENAC (617)
CERTOLIZUMAB PEGOL (580)
Which EVOLOCUMAB Alternatives Have Lower Laryngitis Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE